WuXi AppTec Wins SCRIP Award for "Best Company in an Emerging Market"
News Dec 11, 2014
WuXi PharmaTech announced that it has won the SCRIP Award in the category of "Best Company in an Emerging Market." This is the first time a China-based company has won this SCRIP Award. WuXi AppTec was presented with the award at the 10th Annual SCRIP Awards ceremony held inLondon on December 3, 2014.
Established in 2005 by SCRIP Intelligence, a leading industry news and strategic analysis firm covering the global pharmaceutical and biotech sectors, the annual SCRIP Awards acknowledge the most significant achievements of outstanding companies worldwide.
"We are greatly honored to receive this prestigious industry award and to play a role in helping our partners develop innovative products through our open-access capability and technology platform," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "This award belongs to our employees and collaborative partners around the globe, whose efforts, ingenuity and dedication are making a real difference in the quest to discover and develop new medicines for patients."
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE